Canadian producer Aurora Cannabis has struck a $40 million stock deal to purchase U.S. hemp firm Reliva, checking off a long-stated ambition for the Alberta company’s executives to enter the United States market. Under the terms of the acquisition, Aurora will pay $40...
South Korea’s sovereign wealth fund bought up three Canadian cannabis stocks as they dipped to 52-week lows in the first quarter of 2020.
Cannabis store entrepreneurs are crediting Ontario’s regulator for its quick transition to a virtual inspection regime amid the coronavirus pandemic, saying the move has been key to increasing the number of legal stores in a province facing a serious retail shortage....
An emergency provision temporarily allowing privately owned cannabis stores in Ontario to offer home delivery and curbside pickup has again been extended by the provincial government, and retailers are now allowed to open their doors under certain stipulations. The...
Aurora Cannabis, deep in the red, accepted an offer for its large greenhouse in Exeter, Ontario for what appears to be approximately half of its 17 million Canadian dollar ($12.1 million) listing price, and one-third of the original purchase price. The deal comes amid...
Aurora Cannabis improved its net loss to 137 million Canadian dollars ($97 million) in its third quarter, a significant improvement over the company's CA$1.3 billion net loss in the previous three-month period. The Alberta cannabis producer’s adjusted EBITDA loss for...
Hexo is the latest Canadian cannabis producer to run afoul of the New York Stock Exchange’s continued listing standards because of a low stock price.
Work was temporarily suspended at a cannabis greenhouse in Ontario owned by a one of Tilray’s subsidiaries earlier this week after a worker tested positive for COVID-19.
A cannabis staffing agency in Toronto has launched a public database to connect displaced marijuana professionals with prospective employers. The initiative comes as struggling marijuana firms eliminated an estimated 2,700 positions in Canada over the past nine months...
GW Pharmaceuticals lost $8 million in its latest quarter - an improvement over the previous three-month period - but the United Kingdom-based medical cannabinoid company warned the COVID-19 pandemic could impact sales if fewer patients visit their doctors. Revenue in...
Nanaimo, British Columbia-headquartered Tilray reported a net loss of $184.1 million for its quarter ending March 31, an improvement from the previous period’s $219.1 million loss. Tilray’s adjusted EBITDA loss of $19.7 million was 44% better than the $35.3 million...
The Ontario Cannabis Store is aiming to create a “robust” regulated marketplace of seed varieties in an attempt to wrest market share from entrenched illicit sellers. The provincial wholesaler is currently onboarding seeds from two companies and is in talks with...
